<DOC>
	<DOC>NCT00141193</DOC>
	<brief_summary>This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37 (Year 3) of study drug administration.</brief_summary>
	<brief_title>Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Adenomatous Polyps</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>The subject has had a documented colonoscopy to the cecum performed by a studyrelated physician with adequate preparation resulting in diagnosis and clearance of an adenomatous polyp(s) within 4 months prior to randomization. The subject is willing to abstain from chronic use of all NSAIDs or COX2 inhibitors excluding aspirin at cardioprotective doses for the duration of the study. The subject has a history of Familial Adenomatous Polyposis or Hereditary NonPolyposis Colorectal Cancer. The subject has a history of inflammatory bowel disease.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>